A Alavi
Overview
Explore the profile of A Alavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
472
Citations
7426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willatt M, Alavi A
J Chem Phys
. 2024 Jun;
160(23).
PMID: 38884397
The interaction between the magnetic moment of an electron and the magnetic field generated by a moving charge is one component of the spin-orbit interaction. The nuclei in a molecule...
2.
Broomhead T, Baker S, Martin N, McKenna G, El-Dhuwaib B, Alavi A, et al.
Gerodontology
. 2024 Jan;
41(3):314-327.
PMID: 38247018
Objective: Examine the literature on the experiences of living with removable dentures (complete or partial) to identify any gaps and provide a map for future research. Background: Increasing proportions of...
3.
Hoilund-Carlsen P, Perry G, Alavi A, Barrio J
J Prev Alzheimers Dis
. 2024 Jan;
11(1):259-260.
PMID: 38230739
No abstract available.
4.
Evanson D, Griffin M, OReilly S, Johnson T, Werner T, Kothekar E, et al.
Eur J Nucl Med Mol Imaging
. 2023 Dec;
51(5):1444-1450.
PMID: 38095673
Purpose: To assess radiation therapy (RT)-induced vasculitis in patients with non-small cell lung cancer (NSCLC) by examining changes in the uptake of F-fluoro-D-deoxyglucose ([F]FDG) by positron emission tomography/computed tomography (PET/CT)...
5.
Hoilund-Carlsen P, Alavi A, Perry G, Barrio J
AJNR Am J Neuroradiol
. 2022 Dec;
44(1):E4-E5.
PMID: 36574317
No abstract available.
6.
Ramirez-GarciaLuna J, Wang S, Yangzom T, Piguet V, Kirby J, Alavi A
Br J Dermatol
. 2021 Nov;
186(4):723-726.
PMID: 34748648
No abstract available.
7.
Gulliver W, Alavi A, Wiseman M, Gooderham M, Rao J, Alam M, et al.
J Eur Acad Dermatol Venereol
. 2021 Aug;
35(12):2431-2439.
PMID: 34378812
Background: Long-term, real-word data are needed to help manage patients with hidradenitis suppurativa (HS) through this recurrent, painful and debilitating disease. Objectives: To primarily measure real-world effectiveness of adalimumab in...
8.
Croitoru D, Sibbald C, Alavi A, Brooks S, Piguet V
Br J Dermatol
. 2021 Jun;
185(5):1047-1048.
PMID: 34105770
No abstract available.
9.
Silverberg J, Pinter A, Alavi A, Lynde C, Bouaziz J, Wollenberg A, et al.
J Eur Acad Dermatol Venereol
. 2021 Mar;
35(7):1562-1568.
PMID: 33711179
Background: Nemolizumab is a humanized anti-IL-31 receptor blocker in phase 3 for atopic dermatitis (AD). Objective: Analyse onset of action of nemolizumab 30 mg and compare efficacy and safety vs...
10.
Machado M, Lu J, Brar R, Kirby J, Garg A, Lowes M, et al.
Br J Dermatol
. 2020 Nov;
184(4):772-774.
PMID: 33205398
No abstract available.